Amphastar Pharmaceuticals, Inc. (AMPH)
AMPHNASDAQ-GSBiotechnology: Pharmaceutical Preparations
$29.38
0.0000 (0.00%) today
At the close, Nov 9, 4:00 PM ET. Pre-market $29.80 +1.43%
- Market cap
- $1.27bn
- P/E
- 11.0
- EPS, last 4 quarters
- $2.68
- Dividend yield
- –
- Day range
- –
- 52-week range
- $16.65 to $31.00
- Average volume
- 488.7k
- Previous close
- $29.38
Analysts
5 coveringUnderperform0 buy, 4 hold, 1 sell
Targets a year out average $25.25, -14.1% from here
Earnings
next estimate $0.6800Next report
Dec 2025
-31.5%
Mar 2026
-58.1%
Jun 2026
+56.9%
Sep 2026
+26.3%
estimate reported, and the surprise
Financials
| Quarter | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
| Revenue | $183.10m | $171.17m | $183.90m | $207.61m |
| Gross profit | $85.67m | $70.32m | $93.47m | $99.63m |
| Operating income | $35.61m | $13.63m | $39.73m | $50.77m |
| Net income | $24.43m | $6.42m | $30.35m | $37.76m |
Last four quarters: revenue $745.79m, margin 13.3%, free cash flow $139.01m
News
8 latest- Amphastar (AMPH) Q3 2026 Earnings Call TranscriptThe Motley Fool · 4 days ago
- Amphastar Pharmaceuticals Q3 Earnings Call HighlightsMarketBeat · 5 days ago
- Amphastar (AMPH) Q3 Earnings: Taking a Look at Key Metrics Versus EstimatesZacks · 5 days ago
- Amphastar Pharmaceuticals (AMPH) Tops Q3 Earnings and Revenue EstimatesZacks · 5 days ago
- BridgeBio Pharma (BBIO) Reports Q3 Loss, Beats Revenue EstimatesZacks · Oct 29, 2026
- Analysts Estimate Amphastar Pharmaceuticals (AMPH) to Report a Decline in Earnings: What to Look Out forZacks · Oct 29, 2026
- Bausch Health (BHC) Surpasses Q3 Earnings and Revenue EstimatesZacks · Oct 28, 2026
- Should Value Investors Buy Amphastar Pharmaceuticals (AMPH) Stock?Zacks · Oct 6, 2026
The company
Amphastar is a biopharmaceutical company that focuses on developing, manufacturing, and commercializing technically challenging generic and proprietary injectable, inhalation, and intranasal products. Additionally, the Company sells active pharmaceutical ingredient, or API products. Most of the Company's finished products are contracted and distributed through group purchasing organizations, drug wholesalers, and drug retailers.
- Sector
- Health Care
- Industry
- Biotechnology: Pharmaceutical Preparations
- Exchange
- NASDAQ-GS
- Region
- North America
- Website
- amphastar.com
Often looked at with it
Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.